A Zurich-based international body dedicated to advancing clinical governance, patient safety, and institutional accountability since 1978.
ARAMAS was established to address the growing need for a unified, evidence-based framework governing clinical quality, institutional risk, and patient safety. Today, the Alliance represents over 120 member nations and has certified more than 5,400 healthcare institutions worldwide.
Our work spans three interconnected domains: Assessment & Audit, providing the rigorous evaluation methodologies that benchmark institutional performance; Risk Management, delivering the frameworks that anticipate and mitigate clinical, operational, and regulatory liabilities; and Medical Assurance, establishing the certification standards that ensure continuity of safe, high-quality care across borders.
The ARAMAS Assessment Protocol (AAP) provides a standardised methodology for evaluating healthcare institutions across 12 core domains, including governance structure, clinical competency, infrastructure safety, pharmaceutical management, and patient outcomes tracking. Assessments are conducted by accredited ARAMAS auditors and follow the Alliance's Structured Assessment Cycle — a multi-phase process involving self-assessment, peer review, on-site inspection, and corrective action verification.
Each assessment cycle produces a detailed institutional profile benchmarked against regional and global standards, enabling targeted improvements and strategic resource allocation. Institutions receive actionable recommendations prioritised by clinical impact and feasibility.
Independent clinical audits form the backbone of institutional accountability. ARAMAS-commissioned audits examine clinical documentation accuracy, adverse event reporting completeness, infection control compliance, medication safety protocols, and staff credentialing integrity. Our audit methodology is aligned with the International Society for Quality in Health Care (ISQua) principles and is recognised by national health authorities in over 80 jurisdictions.
The ARAMAS Audit Bureau deploys multidisciplinary teams comprising clinicians, governance specialists, and data analysts. Every audit generates structured findings mapped to the Alliance's 28-point compliance matrix, ensuring consistency and comparability across institutions and regions.
The ARAMAS Clinical Risk Framework (CRF) provides institutions with a structured approach to identifying, categorising, and mitigating risks across surgical, diagnostic, pharmaceutical, and administrative domains. The CRF integrates failure mode and effects analysis (FMEA), root cause analysis (RCA), and prospective hazard assessment into a unified risk register that institutions maintain as a living document.
Version 4.2 of the framework incorporates AI-assisted risk scoring for surgical environments, providing real-time risk stratification during high-acuity procedures. The CRF is complemented by the ARAMAS Incident Learning System, a confidential reporting platform that aggregates anonymised safety data from participating institutions to identify emerging risk patterns.
ARAMAS Safety Standards cover environmental controls (air quality, waste management, radiation protection), clinical safety (surgical safety checklists, patient identification protocols, fall prevention), and data security (electronic health record integrity, patient privacy, cybersecurity for medical devices). Standards are updated on a biennial cycle and are developed in collaboration with the WHO, IEC, and ISO technical committees.
Our compliance advisory service supports institutions in navigating the complex regulatory landscapes across jurisdictions — from the EU Medical Device Regulation (MDR) and Clinical Trials Regulation (CTR) to the US Joint Commission standards and Australian NSQHS Standards. ARAMAS maintains a regulatory intelligence database covering 95 national frameworks, updated quarterly.
At the core of every ARAMAS programme is the principle that patient safety is non-negotiable. Our Medical Assurance framework establishes minimum standards for clinical outcomes measurement, sentinel event response, informed consent processes, and continuity of care during patient transfers. The ARAMAS Patient Safety Index (PSI) tracks 28 validated indicators across mortality, morbidity, readmission, and patient-reported outcomes.
The PSI has been adopted as a reference framework for acute care institutions, marking a milestone in global patient safety harmonisation. Institutions using the PSI report measurable improvements in clinical outcomes within the first two assessment cycles.
ARAMAS publishes an annual set of Clinical Quality Indicators (CQIs) that benchmark institutional performance against evidence-based thresholds. Indicators span surgical site infection rates, medication error frequency, diagnostic turnaround times, ICU length of stay, and patient satisfaction scores. Participating institutions receive confidential benchmarking reports comparing their performance against regional and global medians.
ARAMAS offers three tiers of institutional certification: Certified (meeting baseline standards across all domains), Advanced (demonstrating sustained excellence and continuous improvement), and Gold Standard (reserved for institutions achieving top-decile performance on all clinical quality indicators for three consecutive cycles). Accreditation is valid for four years, with mandatory interim surveillance audits at the two-year mark.
The Gold Standard designation is the highest recognition of institutional governance maturity in the ARAMAS system. Fewer than 6% of certified institutions hold this distinction, representing the global benchmark for clinical excellence.
ARAMAS is governed by an Executive Council comprising representatives from each of the Alliance's six regional bureaux. The Council is supported by Technical Committees that develop and maintain standards, an Independent Audit Board that oversees the integrity of certification decisions, and a Stakeholder Advisory Panel that ensures patient and public perspectives inform policy development.
Nearly five decades of advancing clinical governance and patient safety worldwide.
ARAMAS was founded in 1978 by a consortium of European healthcare regulators and clinical governance specialists who recognised the need for harmonised quality standards in an increasingly interconnected healthcare landscape. Initially focused on hospital accreditation in Western Europe, the Alliance expanded its mandate through the 1990s to encompass clinical risk management, patient safety, and medical device oversight.
Key milestones include the launch of the Clinical Risk Framework in 1994, the adoption of the ARAMAS Assessment Protocol by the WHO South-East Asia Regional Office in 2003, the introduction of the Gold Standard certification tier in 2010, and the endorsement of the ARAMAS Patient Safety Index for global acute care use.
The Alliance's growth has been shaped by a commitment to evidence-based governance and a recognition that healthcare quality transcends national boundaries. Today, ARAMAS operates through six regional bureaux, maintains partnerships with major international health organisations, and continues to set the pace for innovation in clinical safety and institutional accountability.
Looking ahead, the Alliance is investing in digital health governance, AI-assisted risk assessment, and cross-border data sharing frameworks that will define the next generation of medical assurance standards.
ARAMAS operates through six regional bureaux, each responsible for programme delivery, auditor accreditation, and stakeholder engagement within their jurisdiction.
